Your shopping cart is currently empty

L-Octanoylcarnitine hydrochloride (C8:0) is a medium-chain acylcarnitine and a physiologically active plasma metabolite of octanoylcarnitine. It serves as an essential intermediate in the mitochondrial beta-oxidation pathway, facilitating the transport of medium-chain fatty acids across the mitochondrial membrane. It is widely utilized in research concerning breast cancer metabolism, arterial stiffness in overweight individuals, and mitochondrial dysfunction. Elevated levels of C8 carnitine are often indicative of incomplete fatty acid oxidation and are closely linked to oxidative stress and metabolic disorders.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 mg | $40 | - | In Stock | |
| 10 mg | $64 | - | In Stock | |
| 25 mg | $152 | - | In Stock | |
| 50 mg | $255 | - | In Stock | |
| 100 mg | $396 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $44 | - | In Stock |
| Description | L-Octanoylcarnitine hydrochloride (C8:0) is a medium-chain acylcarnitine and a physiologically active plasma metabolite of octanoylcarnitine. It serves as an essential intermediate in the mitochondrial beta-oxidation pathway, facilitating the transport of medium-chain fatty acids across the mitochondrial membrane. It is widely utilized in research concerning breast cancer metabolism, arterial stiffness in overweight individuals, and mitochondrial dysfunction. Elevated levels of C8 carnitine are often indicative of incomplete fatty acid oxidation and are closely linked to oxidative stress and metabolic disorders. |
| In vitro | L-Octanoylcarnitine hydrochloride (0.2 mM) induces H2O2 release in mitochondria, suggesting it promotes oxidative stress by interfering with the electron transport chain, a mechanism relevant to neurodegeneration and metabolic damage [1]. |
| In vivo | In obesity models, L-Octanoylcarnitine hydrochloride dysregulation is linked to impaired detrusor mitochondrial function and bladder dysfunction [2]. |
| Molecular Weight | 323.86 |
| Formula | C15H30ClNO4 |
| Cas No. | 54377-02-5 |
| Smiles | [C@H](OC(CCCCCCC)=O)(C[N+](C)(C)C)CC(O)=O.[Cl-] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (247.02 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.